Inventor · disambiguated record
Stephen L. Gwaltney
Also filed as: GWALTNEY II STEPHEN L · GWALTNEY II STEPHEN LEYCESTER · GWALTNEY STEPHEN · GWALTNEY STEPHEN L
52 granted patents·30 pending applications·452 citations·filing 1999–2025
98Inventor score
Files withGLOBAL BLOOD THERAPEUTICS INC17TAKEDA PHARMACEUTICAL15FENG JUN8TAKEDA SAN DIEGO INC6ABBOTT LAB5
Top patents by PatentIndex Score
82 records- 0197US9957250B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·19 cites·6 claims
- 0297US9802900B2Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 31, 2017·39 cites·20 claims
- 0395US6521658B1Cell proliferation inhibitorsABBOTT LAB·Filed 2000·Granted Feb 18, 2003·59 cites·11 claims
- 0494US7781584B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Aug 24, 2010·17 cites·4 claims
- 0594US7169926B1Dipeptidyl peptidase inhibitorsARRAY BIOPHARMA INC·Filed 2004·Granted Jan 30, 2007·68 cites·72 claims
- 0693US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 0792US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 0892US7732446B1Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Jun 8, 2010·15 cites·25 claims
- 0990US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 1090US7795428B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Sep 14, 2010·12 cites·59 claims
- 1188US7470700B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Dec 30, 2008·23 cites·31 claims
- 1287US7960384B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Jun 14, 2011·6 cites·49 claims
- 1387US7872124B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Jan 18, 2011·9 cites·15 claims
- 1486US8288539B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted Oct 16, 2012·6 cites·31 claims
- 1586US8008332B2Substituted indazoles as glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2007·Granted Aug 30, 2011·9 cites·49 claims
- 1685US8188275B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted May 29, 2012·4 cites·4 claims
- 1785US8178555B2Apoptosis signal-regulating kinase 1 inhibitorsCHANG EDCON·Filed 2009·Granted May 15, 2012·13 cites·58 claims
- 1885US8173663B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted May 8, 2012·5 cites·29 claims
- 1985US7906523B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted Mar 15, 2011·4 cites·15 claims
- 2085US7550590B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Jun 23, 2009·20 cites·16 claims
- 2184US12030866B22-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEADTHE KATHOLIEKE UNIV LEUVEN·Filed 2022·Granted Jul 9, 2024·2 cites·21 claims
- 2282US8222411B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2006·Granted Jul 17, 2012·8 cites·5 claims
- 2379US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 2479US2023322704A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2578US7687638B2Dipeptidyl peptidase inhibitorsTAKEDA SAN DIEGO INC·Filed 2005·Granted Mar 30, 2010·5 cites·34 claims
- 2675US11530191B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 2774US2022402940A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2873US8163779B2Glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2007·Granted Apr 24, 2012·2 cites·18 claims
- 2973US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 3072US12336982B2Compositions and methods of modulating short-chain dehydrogenase activityRODEO THERAPEUTICS CORP·Filed 2019·Granted Jun 24, 2025·1 cites·83 claims
- 3172US8563730B2Pyrazole and fused pyrazole glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2009·Granted Oct 22, 2013·1 cites·52 claims
- 3271US8530499B2Glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2012·Granted Sep 10, 2013·2 cites·12 claims
- 3371US7825242B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Nov 2, 2010·1 cites·15 claims
- 3471US6228868B1Oxazoline antiproliferative agentsABBOTT LAB·Filed 1999·Granted May 8, 2001·32 cites·7 claims
- 3570US2022119407A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3669US8034822B2Glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2007·Granted Oct 11, 2011·1 cites·23 claims
- 3769US7790734B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Sep 7, 2010·4 cites·95 claims
- 3868US7790736B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Sep 7, 2010·2 cites·64 claims
- 3967US11236109B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Feb 1, 2022·0 cites·8 claims
- 4067US11053195B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jul 6, 2021·0 cites·11 claims
- 4167US10829470B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·11 claims
- 4267US8133898B2Renin inhibitorsGWALTNEY STEPHEN L·Filed 2008·Granted Mar 13, 2012·1 cites·21 claims
- 4366US9695166B2Pyrazolopyridine pyrazolopyrimidine and related compoundsGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Jul 4, 2017·1 cites·40 claims
- 4465US8329900B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2007·Granted Dec 11, 2012·0 cites·16 claims
- 4565US2024383891A1Benzimidazole and related analogs for inhibiting yap/taz-teadSPRINGWORKS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4665US2024409556A1Benzopiperazine and related analogs for inhibiting yap/taz-teadSPRINGWORKS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4764US2016083343A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4863US2019010121A1Compounds and uses thereof for the modulation of hemobloginGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4963US2016024127A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5062US6924304B2Cell proliferation inhibitorsABBOTT LAB·Filed 2002·Granted Aug 2, 2005·2 cites·8 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen L. Gwaltney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →